Provides extremely precise temperature measurement systems for semiconductor construction/manufacturing. All 5 of the large semiconductor makers are clients. New management streamlined the company. They have increasing orders, lots of cash and high expected future earnings. However, semiconductors are a cyclical business and cellphone sales have been slowing significantly. They are being brought into more aspects of the manufacturing process and their benefit is making the manufacturer more efficient, so their opportunity is still significant going forward. They will probably make an acquisition with their cash but he doesn’t know what they might buy or how it will help them. (Analysts’ price target is $2.95)

The market doesn’t like the uncertainty associated with this company, which includes a change of management (in progress) and delay of approval of their planned acquisition of another business in the USA. He thinks the stock is overpriced relative to expected earnings growth. It has negative free cash flow. Dividend coverage is good but with negative cash flow, he doesn’t expect dividend growth.

He thinks there is good opportunity for this medical device manufacturer with the arrival of a new CEO. Note: His wife works as a consultant for this company.

All three of the auto parts makers--Martinrea, Linamar (LNR-T) and Magna (MG-T) are at significant risk if the US imposes its auto tariff. Setting aside the risk, MRE ranks better in his database than the other two. He sold MRE and LNR in order to lock in his profits as the price declined. He may soon sell Magna. He will not consider buying them until their prices start to improve.

They design and build turnkey manufacturing and test systems. Doesn’t pay a dividend, but he thinks it is coming out of a long sleep with great opportunities as many companies bring manufacturing back to North America. They had a big earnings surprise this quarter and analysts’ forecasts have been revised significantly upward. Looking at the technical pattern, he thinks there is a possible 50% upside. (Analysts’ price target is $22.40)

This has a modest 1% dividend that is well-covered. Their sales and earnings were up 9% and 14% in their July report. He expects earnings growth to be 17% this year and 13% next year. Looking at the technical pattern, he thinks there is a possible 41% upside. (Analysts’ price target is $273.34)

This is the parent of Sobeys. They are shaving costs. Earnings have been growing phenomenally even though sales are almost flat. They offer a 1.7% dividend and have a 6.1% free cash flow yield with strong projected earnings growth. (Analysts’ price target is $29.18)